APHL NewSTEPs National Webinar: Upcoming Newborn Screening Conditions

This webinar provides an overview of five candidate conditions and their suitability for newborn screening. The conditions will include pyruvate dehydrogenase complex deficiency (PDCD), cerebrotendinous xanthomatosis (CTX), congenital cytomegalovirus (cCMV), metachromatic leukodystrophy (MLD), and other mucopolysaccharidosis (MPS) conditions such as MPS types IV, VI, and VII. 

Objectives:

The webinar objectives include to:

• Provide an overview of the candidate conditions for newborn screening.
• Describe potential screening methods.
• Discuss the potential benefits and challenges associated with screening these conditions within newborn screening.
• To address any concerns or questions regarding the implementation of screening for these conditions.

Moderators:

• George Dizikes, PhD, HCLD/CC (ABB), Clinical Consultant, Illinois Department of Health
• Amy Gaviglio, MS, CGC, Genetics and Public Health Consultant, Connetics Consulting

Speakers:

• Laura Adang, MD, PhD, MSTR, Assistant Professor of Neurology, Wadsworth Center, New York State Department of Health
• Jirair K. Bedoyan, MD, PhD, FACMG, Assistant Professor of Pediatrics, University of Pittsburgh School of Medicine, Program Director, UPMC Children's Hospital of Pittsburgh
• Michele Caggana, ScD, FACMG, Program Director Wadsworth Center, New York State Department of Health
• Matthew Ellinwood, DVM, PhD, Chief Scientific Officer, National MPS Society
• Andrea DeBarber, PhD, Research Associate Professor, Oregan Health & Science University
• Austin Larson, MD, Assistant Professor, University of Colorado School of Medicine